Click here
to support our affiliates
in raising money
for cancer research!
- Cancer Info
- PolyMVA
- PolyMVA for Pets
- Tips for Family and Caregivers
- Patient Checklist
- Glossary of Cancer Terms
- Find a Naturopathic Doctor
- Goodsearch.com
- BuyforCharity.com
- Options for Financial Support
- Participate in a Quality of Life Study
- Press Releases
- Donate
Newsletter
Team Up!
Against Cancer
Against Cancer
Team Up! Against Cancer puts cancer surviors together with cancer patients and their families, in the church and in the community.
Oncolink
Get current and comprehensive information about specific types of cancer, updates on cancer treatments and news about research advances.
CaringBridge
CaringBridge is a nonprofit organization offering free, personalized websites that allow people to stay in touch with family and friends during a health crisis, treatment and recovery.
Health Search
Brought to you by:
CancerMonthly.com
and
SurvivingMesothelioma.com
Stories
Hana says FDA to review cancer nausea drug
Wed Aug 30, 8:24 AM ET
Cancer-focused biotechnology firm Hana Biosciences said on Wednesday the U.S. Food and Drug Administration had accepted Zensana Oral Spray for review.
The company said it expects Zensana, a drug aimed at preventing chemotherapy, radiation, and post-operative associated nausea and vomiting, to be launched in the United States in the first half of 2007, subject to FDA approval.
Read More...
Read More...
NIH: Company influenced sepsis treatment
By JEFF DONN and MARILYNN MARCHIONE, Associated Press WritersWed Oct 18, 5:34 PM ET
Several government doctors say drug maker Eli Lilly & Co. subtly orchestrated medical guidelines for treatment of an often-lethal blood infection, hoping to boost sales of a drug whose value is being debated.
Such involvement could open another door to corporate interests trying to shape health care, beyond funding experiments and cozying up to doctors in...
Read More...
Read More...
Pre-op chemotherapy aids young cancer patients
Tue Oct 10, 9:28 AM ET
Children with advanced kidney cancer may suffer fewer long-term side effects and need less treatment if they are given chemotherapy to shrink their tumor before surgery, researchers said on Tuesday.
Wilms' tumor is the most common type of kidney cancer that affects children. In most cases it is curable.
Chemotherapy is normally given after surgery to kill any remaining cancer cells in the body. But British...
Read More...
Read More...
FDA News
FOR IMMEDIATE RELEASE
P06-162
October 6, 2006 Media Inquiries:
Megan Moynahan, 301-827-6242
Consumer Inquiries:
888-INFO-FDA
FDA Approves New Drug for Skin Cancer, Zolinza
The U.S. Food and Drug Administration (FDA) today approved Zolinza (vorinostat) capsules for the treatment of cutaneous T-cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines.
Zolinza...
Read More...
Read More...
Just Say ‘Know’ to Prescription Drugs Campaign Finds International Interest and Support
Mon Oct 2, 11:55 AM ET
New York, NY (PRWEB) October 2, 2006 -- Today the Just Say “Know” to Prescription Drugs campaign, aimed at getting one million people to stop and reevaluate the medications they are taking, reported that interest in the initiative is coming from a wide array of countries around the globe. Though 79 percent of the inquires about the initiative are coming from the...
Read More...
Read More...
Chemo has long-term impact on brain function
Thu Oct 5, 9:15 AM ET
Chemotherapy causes changes in the brain's metabolism and blood flow that can last as long as 10 years, a discovery that may explain the mental fog and confusion that affect many cancer survivors, researchers said on Thursday.
The researchers, from the University of California, Los Angeles, found that women who had undergone chemotherapy five to 10 years earlier had lower metabolism in a key region of the frontal...
Read More...
Read More...
High-Tech Radiation Boosts Prostate Cancer Survival
Fri Oct 6, 11:48 PM ET
FRIDAY, Oct. 6 (HealthDay News) -- Most prostate cancer patients treated with high-dose, intensity modulated radiation therapy (IMRT) were still alive and cancer-free an average of eight years after treatment, according to a large new study.
The study -- the first to describe long-term outcomes for prostate cancer patients treated with IMRT -- was conducted by a team from Memorial Sloan-Kettering Cancer...
Read More...
Read More...
Healthy Cholesterol Levels Could Lower Prostate Cancer Risk
By Janice Billingsley
HealthDay ReporterFri Oct 6, 11:48 PM ET
FRIDAY, Oct. 6 (HealthDay News) -- Doctors have long known that lowering your cholesterol levels helps protect your heart. But could it also reduce the risk of prostate cancer for men?
Researchers are increasingly optimistic that the two conditions are related, making what's good for the heart good for the prostate, too.
"This is an upcoming area. There...
Read More...
Read More...
“Death by Medicine” is a paper on medical iatrogenesis—44 pages in length. The definition of iatrogenic is “a symptom or illness brought on unintentionally by something that a doctor does or says.” Much like conventional medicine itself, my dictionary is in denial about iatrogenic deaths. Iatrogenesis is not just about symptoms or illness—incredibly, I found that in the U.S. there are 783,936 deaths annually due to medicine’s effects.
I wrote “Death by Medicine”...
Read More...
Read More...
XanGo juice drink maker gets FDA warning
Tue Oct 3, 3:03 PM ET
The U.S. Food and Drug Administration has warned the maker of tropical fruit drink XanGo over claims the beverage can prevent or treat cancer, depression, infection, Alzheimer's disease and other ailments.
In a September 20 letter to XanGo LLC, released on Tuesday, the FDA said brochures for the purple mangosteen beverage also asserted it was "a proven, natural COX-2 inhibitor," referring to painkillers such as...
Read More...
Read More...